Travere Therapeutics, Inc.
TVTX • NASDAQ • Stock Fundamentals
Travere Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric Dube, with a market cap of $4.5B.
Market Cap$4.5B
Employees380.0
CEOEric Dube
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 4, 2026 · 1 month 10 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Travere Therapeutics, Inc. FAQ
Common questions about Travere Therapeutics, Inc.
Travere Therapeutics, Inc. (TVTX) has a market capitalization of $4.5B and trades on NASDAQ.
Travere Therapeutics, Inc. has approximately 380 employees.